首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression.
【24h】

Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression.

机译:地塞米松改变胆道减压后肝修复过程中肝炎性细胞的分布而基质降解无变化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Biliary atresia is characterized by extrahepatic bile duct obliteration along with persistent intrahepatic portal inflammation. Steroids are standard in the treatment of cholangitis following the Kasai portoenterostomy, and were advocated for continued suppression of the ongoing immunologic attack against intrahepatic ducts. Recent reports, however, have failed to demonstrate an improved patient outcome or difference in the need for liver transplant in postoperative patients treated with a variety of steroid regimes compared with historic controls. In the wake of progressive liver disease despite biliary decompression, steroids are hypothesized to suppress inflammation and promote bile flow without any supporting data regarding their effect on the emerging cellular and molecular mechanisms of liver repair. We have previously shown in a reversible model of cholestatic injury that repair is mediated by macrophages, neutrophils, and specific matrix metalloproteinase activity (MMP8); we questioned whether steroids would alter these intrinsic mechanisms. METHODS: Rats underwent biliary ductal suspension for 7 d, followed by decompression. Rats were treated with IV dexamethasone or saline at the time of decompression. Liver tissue obtained at the time of decompression or after 2 d of repair was processed for morphometric analysis, immunohistochemistry, and quantitative RT-PCR. RESULTS: There was a dramatic effect of dexamethasone on the inflammatory component with the initiation of repair. Immunohistochemistry revealed a reduction of both ED1+ hepatic macrophages and ED2+Kupffer cells in repair compared with saline controls. Dexamethasone treatment also reduced infiltrating neutrophils by day 2. TNF-alpha expression, increased during injury in both saline and dexamethasone groups, was markedly reduced by dexamethasone during repair (day 2) whereas IL-6, IL-10, and CINC-1 remained unchanged compared with saline controls. Dexamethasone reduced both MMP8 and TIMP1 expression by day 2, whereas MMP9, 13, and 14 were unchanged compared with sham controls. Despite substantial cellular and molecular changes during repair, collagen resorption was the same in both groups CONCLUSION: Dexamethasone has clear effects on both the hepatic macrophage populations and infiltrating neutrophils following biliary decompression. Altered MMP and TIMP gene expression might suggest that steroids have the potential to modify matrix metabolism during repair. Nevertheless, successful resorption of collagen fibrosis proceeded presumably through other MMP activating mechanisms. We conclude that steroids do not impede the rapid intrinsic repair mechanisms of matrix degradation required for successful repair.
机译:背景:胆道闭锁的特征是肝外胆管闭塞以及持续的肝内门静脉炎症。类固醇是治疗Kasai肠胃造口术后胆管炎的标准方法,并被提倡持续抑制对肝内导管的持续免疫攻击。然而,最近的报道未能证明与传统对照相比,在接受各种类固醇治疗的术后患者中,患者的预后改善或肝移植需求有所不同。尽管胆道减压,但在进行性肝病之后,假设类固醇可抑制炎症并促进胆汁流动,而没有任何有关其对新兴的肝修复细胞和分子机制的影响的支持性数据。我们先前在胆汁淤积性损伤的可逆模型中显示,修复是由巨噬细胞,嗜中性粒细胞和特定的基质金属蛋白酶活性(MMP8)介导的。我们质疑类固醇是否会改变这些内在机制。方法:大鼠进行胆道导管悬吊7 d,然后减压。在减压时用静脉地塞米松或盐水治疗大鼠。对减压时或修复2天后获得的肝组织进行形态分析,免疫组织化学和定量RT-PCR。结果:随着修复的开始,地塞米松对炎症成分产生了显着影响。免疫组织化学显示,与盐水对照组相比,修复后的ED1 +肝巨噬细胞和ED2 + Kupffer细胞均减少。地塞米松治疗也可在第2天减少浸润的中性粒细胞。在盐水和地塞米松组的损伤过程中增加的TNF-α表达在修复期间(第2天)被地塞米松显着降低,而IL-6,IL-10和CINC-1仍然存在与盐水对照组相比没有变化。与假对照组相比,地塞米松可在第2天降低MMP8和TIMP1的表达,而MMP9、13和14则保持不变。尽管修复过程中细胞和分子发生了实质性变化,但两组胶原吸收相同。结论:地塞米松对胆管减压后的肝巨噬细胞群和浸润性中性粒细胞都有明显的影响。 MMP和TIMP基因表达的改变可能表明类固醇可能在修复过程中改变基质代谢。然而,胶原纤维化的成功吸收大概是通过其他MMP激活机制进行的。我们得出的结论是,类固醇不会阻碍成功修复所需的基质降解的快速内在修复机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号